Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level

Atchison, 2003, Transcription factor YY1 functions as a PcG protein in vivo, EMBO J., 22, 1347, 10.1093/emboj/cdg124 Srinivasan, 2005, Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue, J. Cell. Biochem., 96, 689, 10.1002/jcb.20562 Wang, 2016, Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells, Cell. Signal., 28, 506, 10.1016/j.cellsig.2016.02.006 Zhang, 2016, Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation, J. Mol. Cell Biol., 8, 232, 10.1093/jmcb/mjw002 Li, 2019, Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1beta-induced fatty acid oxidation, Theranostics, 9, 7599, 10.7150/thno.34931 Gao, 2019, Yin Yang 1 protein ameliorates diabetic nephropathy pathology through transcriptional repression of TGFbeta1, Sci. Transl. Med., 11, 10.1126/scitranslmed.aaw2050 Tan, 2019, Yin Yang 1 suppresses dilated cardiomyopathy and cardiac fibrosis through regulation of Bmp7 and ctgf, Circ. Res., 125, 834, 10.1161/CIRCRESAHA.119.314794 Kaufhold, 2016, Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication, J. Exp. Clin. Cancer Res., 35, 84, 10.1186/s13046-016-0359-2 Matsumura, 2009, Yin yang 1 modulates taxane response in epithelial ovarian cancer, Mol. Cancer Res., 7, 210, 10.1158/1541-7786.MCR-08-0255 Zheng, 2018, miR-125a-3p inhibits ERalpha transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer, FASEB J., 32, 588, 10.1096/fj.201700461RR Gao, 2019, MiR-873/PD-L1 axis regulates the stemness of breast cancer cells, EBioMedicine, 41, 395, 10.1016/j.ebiom.2019.02.034 Nam, 2008, MicroRNA expression profiles in serous ovarian carcinoma, Clin. Cancer Res., 14, 2690, 10.1158/1078-0432.CCR-07-1731 Jiang, 2014, miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells, Biomed. Pharmacother., 68, 163, 10.1016/j.biopha.2013.12.001 Zhang, 2019, MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer, Eur. Rev. Med. Pharmacol. Sci., 23, 4663 Nagy, 2018, Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets, Sci. Rep., 8, 9227, 10.1038/s41598-018-27521-y Li, 2011, Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29, J. Pathol., 224, 484, 10.1002/path.2873 Van Der Werf, 2019, The yin and Yang of RNA methylation: an imbalance of erasers enhances sensitivity to FTO demethylase small-molecule targeting in leukemia stem cells, Cancer Cell, 35, 540, 10.1016/j.ccell.2019.03.011 Vella, 2012, Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells, Nucleic Acids Res., 40, 3403, 10.1093/nar/gkr1290 Wottrich, 2017, Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer, Drug Resist. Updat., 30, 28, 10.1016/j.drup.2017.01.001 Wang, 2017, YY1 is an inducer of Cancer metastasis, Crit. Rev. Oncog., 22, 1, 10.1615/CritRevOncog.2017021314 Jia, 2019, MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1, Exp. Cell Res., 375, 73, 10.1016/j.yexcr.2018.12.016 Shi, 2019, PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors, Elife, 8, 10.7554/eLife.44306 Kim, 2016, Loss of HDAC-Mediated repression and gain of NF-kappaB activation underlie cytokine induction in ARID1A- and PIK3CA-Mutation-Driven ovarian cancer, Cell Rep., 17, 275, 10.1016/j.celrep.2016.09.003 Balch, 2012, A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells, Cancer Biol. Ther., 13, 681, 10.4161/cbt.20086 Arend, 2013, The Wnt/beta-catenin pathway in ovarian cancer: a review, Gynecol. Oncol., 131, 772, 10.1016/j.ygyno.2013.09.034 Teeuwssen, 2019, Wnt signaling in ovarian Cancer stemness, EMT, and therapy resistance, J. Clin. Med., 8, 10.3390/jcm8101658 Song, 2019, BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/beta-catenin signaling, Eur. J. Pharmacol., 852, 189, 10.1016/j.ejphar.2019.03.018 Wang, 2019, BRD4 promotes glioma cell stemness via enhancing miR-142-5p-mediated activation of Wnt/beta-catenin signaling, Environ. Toxicol. Ma, 2017, Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells, Oncol. Lett., 13, 1681, 10.3892/ol.2017.5630 Zhang, 2020, Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589), Cancer Xue, 2019, HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer, Br. J. Cancer, 121, 1039, 10.1038/s41416-019-0625-0 Dong, 2018, Novel HDAC5-interacting motifs of Tbx3 are essential for the suppression of E-cadherin expression and for the promotion of metastasis in hepatocellular carcinoma, Signal Transduct. Target. Ther., 3, 22, 10.1038/s41392-018-0025-6